samm50b Antibody

What is SAMM50 and what cellular functions does it perform?

SAMM50 (Sorting and Assembly Machinery Component 50 homolog) is an essential protein of the mitochondrial outer membrane (OMM) containing a beta-barrel domain that is evolutionarily conserved from bacteria to humans . It serves as a component of the sorting and assembly machinery (SAM) complex, which primarily functions to integrate beta-barrel proteins into the outer mitochondrial membrane . SAMM50 regulates the biogenesis of β-barrel proteins, including TOMM40 and VDAC1, which are crucial for mitochondrial protein import and metabolite exchange . Additionally, SAMM50 plays a significant role in maintaining cristae stability through interactions with MICOS complex proteins like MIC19 and MIC60 .

Recent research has revealed that SAMM50 also functions as a receptor for basal piecemeal degradation of SAM and MICOS complex proteins through LC3-interacting region (LIR)-dependent recruitment of ATG8 proteins and the autophagy receptor p62/sequestosome 1 (SQSTM1) . This indicates its involvement in mitochondrial quality control mechanisms. Furthermore, polymorphisms in the SAMM50 gene have been associated with the development and progression of nonalcoholic fatty liver disease, suggesting broader implications in metabolic disorders .

What applications are SAMM50 antibodies suitable for in laboratory research?

SAMM50 antibodies have been validated for multiple experimental applications crucial for mitochondrial research. Based on the information from antibody manufacturers and published literature, the following applications have been successfully demonstrated:

The antibodies have demonstrated reactivity with human, mouse, and rat samples , making them versatile tools for comparative studies across different model organisms.

What are the optimal storage conditions for maintaining SAMM50 antibody efficacy?

Storage conditions for SAMM50 antibodies vary slightly between manufacturers but generally follow standard protein preservation protocols. For unconjugated SAMM50 antibodies:

• Store at -20°C for general long-term storage . Some specific formats may require storage at -80°C .

• For conjugation-ready formats in PBS (BSA and azide-free), storage at -80°C is recommended .

• Antibodies formulated in PBS with 0.02% sodium azide and 50% glycerol (pH 7.3) can be stored at -20°C and remain stable for one year after shipment .

• Aliquoting is generally unnecessary for -20°C storage of small volumes (20μl sizes containing 0.1% BSA) .

• Avoid repeated freeze-thaw cycles to maintain antibody performance .

Following these storage guidelines is critical for maintaining antibody specificity and sensitivity, particularly for applications requiring quantitative analysis.

How should researchers optimize SAMM50 antibody conditions for Western blot applications?

Optimizing SAMM50 antibody conditions for Western blot requires careful consideration of several parameters:

Sample Preparation:

• Extract preparation: SAMM50 has been successfully detected in cell lines including A431, HeLa, and HepG2, as well as mouse and rat heart tissues .

• Loading amount: 25μg of protein per lane is typically sufficient for detection .

Antibody Protocol:

• Primary antibody dilution: The recommended range is 1:2000-1:16000 , but optimization for your specific sample and antibody lot is advisable.

• Blocking buffer: 3% nonfat dry milk in TBST has been successfully used .

• Secondary antibody: HRP-conjugated Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution works well with rabbit polyclonal antibodies .

• Detection method: ECL Basic Kit with exposure time of approximately 30 seconds has proven effective .

Expected Results:

• The observed molecular weight of SAMM50 is approximately 52 kDa , consistent with its calculated molecular weight of 52 kDa (469 amino acids) .

• When performing knockdown validation experiments, depletion of SAMM50 affects levels of its interacting partners, including TOMM40 and MICOS complex proteins, which should be considered when interpreting results .

What are the critical considerations for immunohistochemistry applications using SAMM50 antibodies?

Successful immunohistochemistry with SAMM50 antibodies requires attention to several critical factors:

Tissue Preparation and Antigen Retrieval:

• For paraffin-embedded tissues, high-pressure antigen retrieval with 10 mM citrate buffer (pH 6.0) is recommended before commencing the IHC staining protocol .

• Alternative antigen retrieval may be performed with TE buffer pH 9.0 for some antibody formulations .

Protocol Parameters:

• Dilution range: 1:50-1:500 is recommended, with optimization necessary for each specific tissue type .

• Positive control tissues: Human heart tissue, human liver cancer tissue, mouse heart, and rat heart have all been validated for SAMM50 antibody staining .

• Incubation conditions: Typically overnight at 4°C for primary antibody, but this may vary based on antibody concentration and tissue type.

Visualization and Analysis:

• For brightfield microscopy, careful titration of the antibody is essential to achieve optimal signal-to-noise ratio.

• For fluorescence applications, consideration of autofluorescence from mitochondria-rich tissues is important when selecting secondary antibody fluorophores.

• Since SAMM50 is a mitochondrial protein, expected staining patterns should show cytoplasmic distribution with a distinctive mitochondrial network pattern.

How can researchers effectively use SAMM50 antibodies for studying protein-protein interactions?

SAMM50 interacts with multiple protein complexes, making co-immunoprecipitation (co-IP) and related techniques valuable for studying its functional relationships:

Co-Immunoprecipitation Strategy:

• Recommended antibody dilution for IP: 1:500-1:1000 .

• Verified interactions: SAMM50 has been shown to interact with p62/SQSTM1, MICOS complex proteins (MIC19, MIC60), and mitochondrial proteins MTX1 and MTX2 .

• Controls: Include IgG controls from the same species as the SAMM50 antibody to identify non-specific binding.

GST-Pulldown Assays:

• GST-pulldown assays have confirmed direct interactions between SAMM50 and p62, between SAMM50 and MICOS complex proteins, and between SAMM50 and MTX1/2 .

• For recombinant protein production, the immunogen sequence (amino acids 1-220 of human SAMM50) has been successfully used for generating fusion proteins .

Mass Spectrometry Validation:

• Mass spectrometry of proteins immunoprecipitated with endogenous SAMM50 has revealed many of the same mitochondrial proteins found in p62 immunoprecipitates .

• This approach can be used to identify novel interaction partners and validate existing ones.

How can SAMM50 antibodies be utilized to investigate mitophagy mechanisms?

SAMM50 has recently been identified as playing a crucial role in mitophagy, particularly in basal piecemeal mitophagy of SAM and MICOS components. Researchers can leverage SAMM50 antibodies to investigate these processes through several approaches:

Monitoring SAMM50-Mediated Mitophagy:

• SAMM50 recruits ATG8 proteins through an LC3-interacting region (LIR) motif and interacts with p62/SQSTM1 to mediate basal piecemeal mitophagy .

• Researchers can use SAMM50 antibodies in combination with antibodies against LC3B, p62, and specific mitochondrial markers to track this process through immunofluorescence confocal microscopy.

• Dual or triple immunostaining can reveal colocalization patterns indicative of active mitophagy processes.

Experimental Design for OXPHOS-Induced Mitophagy:

• SAMM50 and p62 cooperate to mediate efficient piecemeal mitophagy upon metabolic switch to oxidative phosphorylation (OXPHOS) .

• To study this phenomenon, researchers can induce a metabolic switch to OXPHOS (by glucose limitation and fatty acid supplementation) and monitor changes in SAMM50-p62 interactions and subsequent mitochondrial protein degradation.

• Time-course experiments using SAMM50 antibodies can reveal the dynamics of this process.

SAMM50 Knockdown Effects:

• SAMM50 depletion has been shown to stabilize PINK1 and increase processing of LC3B-I to LC3B-II .

• This can be monitored using Western blot with appropriate antibodies to track changes in these markers of mitophagy.

• It's important to note that while SAMM50 depletion affects protein content, mitochondrial DNA nucleoids are preserved , which should be considered when designing experimental readouts.

What considerations are important when using SAMM50 antibodies to study its role in β-barrel protein biogenesis?

SAMM50 plays a critical role in the biogenesis of β-barrel proteins in the outer mitochondrial membrane. When investigating this function, several considerations are essential:

Experimental Design Considerations:

• SAMM50 regulates the biogenesis of β-barrel proteins, including TOMM40 and VDAC1 . Therefore, these proteins serve as useful readouts of SAMM50 function.

• When designing knockdown or knockout experiments, researchers should be aware that SAMM50 depletion affects the levels of these proteins, potentially leading to disruption of mitochondrial protein import and metabolism.

Methodological Approach:

• Pulse-chase experiments combined with immunoprecipitation using SAMM50 antibodies can track the assembly kinetics of newly synthesized β-barrel proteins.

• Blue native PAGE followed by Western blotting with SAMM50 antibodies can identify intact SAM complexes and intermediate assembly complexes.

• Conditional depletion systems are preferable to constitutive knockdown, as complete loss of SAMM50 may have pleiotropic effects that complicate interpretation.

Analysis and Controls:

• When analyzing the impact of SAMM50 on β-barrel protein biogenesis, it's important to distinguish between direct effects on protein assembly and indirect effects resulting from altered mitochondrial morphology or general mitochondrial dysfunction.

• Controls should include assessment of non-β-barrel mitochondrial proteins to establish specificity.

• Complementation experiments with wild-type SAMM50 or specific mutants can provide insights into structure-function relationships.

How should researchers approach investigating SAMM50's role in nonalcoholic fatty liver disease (NAFLD)?

Polymorphisms in the SAMM50 gene have been associated with the development and progression of nonalcoholic fatty liver disease . When investigating this connection, researchers should consider:

Experimental Models:

• Both cellular models (hepatocytes, hepatoma cell lines) and animal models (particularly mouse models of NAFLD) can be used with SAMM50 antibodies to study expression patterns and functional alterations.

• Patient-derived samples from individuals with different SAMM50 polymorphisms can be analyzed using immunohistochemistry to determine whether protein expression or localization is altered.

Methodological Approaches:

• Immunohistochemistry protocols for liver tissues should be optimized, with particular attention to antigen retrieval methods. Both citrate buffer (pH 6.0) and TE buffer (pH 9.0) have been used successfully .

• Western blot analysis of liver tissue extracts can quantify SAMM50 expression levels in relation to disease progression.

• Co-immunoprecipitation experiments can determine whether SAMM50's interactions with partner proteins are altered in the context of NAFLD.

Functional Studies:

• Since SAMM50 affects mitochondrial function, researchers should consider measuring parameters such as mitochondrial respiration, ROS production, and mitochondrial morphology in conjunction with SAMM50 expression analysis.

• The impact of lipid accumulation on SAMM50 function can be assessed by treating cells with free fatty acids and analyzing changes in SAMM50 expression, localization, or interaction partners.

• CRISPR-mediated introduction of specific NAFLD-associated SAMM50 polymorphisms, followed by functional studies, can provide mechanistic insights.

What are common pitfalls when working with SAMM50 antibodies and how can they be addressed?

Working with SAMM50 antibodies may present several challenges that researchers should be prepared to address:

Specificity Issues:

• Problem: Cross-reactivity with other mitochondrial proteins.

• Solution: Include appropriate controls such as SAMM50 knockdown or knockout samples to verify antibody specificity. Western blot analysis should show a predominant band at 52 kDa .

Signal Intensity:

• Problem: Weak signal in immunohistochemistry or Western blot.

• Solution: For IHC, optimize antigen retrieval using high-pressure methods with either 10 mM citrate buffer (pH 6.0) or TE buffer (pH 9.0) . For Western blot, longer exposure times (beyond the standard 30 seconds) may be necessary depending on expression levels.

Background Issues:

• Problem: High background in immunofluorescence applications.

• Solution: Optimize blocking conditions (duration, buffer composition) and consider using more stringent washing steps. Titration of primary antibody is crucial, with recommended dilutions ranging from 1:50-1:500 for IF/ICC .

Sample Preparation:

• Problem: Inconsistent results between experiments.

• Solution: Standardize protein extraction protocols, particularly for mitochondrial proteins. For mitochondria-enriched fractions, gentle isolation procedures are recommended to maintain protein interactions and complex integrity.

How can researchers validate SAMM50 antibody specificity in their experimental systems?

Validating antibody specificity is critical for ensuring reliable research outcomes. For SAMM50 antibodies, several validation approaches are recommended:

Genetic Validation:

• CRISPR-mediated knockdown or knockout of SAMM50 should result in reduced or absent antibody signal .

• Alternative approaches include siRNA-mediated knockdown, which has been shown to effectively reduce SAMM50 levels .

Orthogonal Detection Methods:

• Compare results from antibodies targeting different epitopes of SAMM50.

• Use recombinant expression of tagged SAMM50 (e.g., GFP-SAMM50) and verify co-localization with antibody staining.

Validation Across Applications:

• If using the antibody for multiple applications (e.g., WB, IF, IHC), consistent results across platforms increases confidence in specificity.

• Observed molecular weight should match the predicted 52 kDa , and subcellular localization should be consistent with mitochondrial distribution.

Positive and Negative Controls:

• Positive controls include tissues and cell lines known to express SAMM50, such as HeLa cells, HepG2 cells, and heart tissue from humans, mice, and rats .

• Negative controls should include samples processed identically but without primary antibody exposure.

How can SAMM50 antibodies be utilized in multiplex imaging approaches for mitochondrial research?

Multiplex imaging technologies offer powerful tools for understanding SAMM50's spatial relationships with other proteins and complexes:

Multiplex Immunofluorescence Approaches:

• SAMM50 antibodies in unconjugated format can be custom-labeled for multiplex imaging applications .

• When designing multiplex panels, combine SAMM50 with markers of mitochondrial subcompartments (e.g., TOMM20 for outer membrane, TIMM23 for inner membrane, matrix proteins) to precisely localize SAMM50 function.

• For studying mitophagy, multiplex panels combining SAMM50 with LC3, p62, and lysosomal markers can provide spatial information about mitophagy progression.

Implementation Strategies:

• Sequential staining protocols with appropriate blocking between rounds can minimize cross-reactivity.

• Spectral unmixing approaches may be necessary when working with tissues with high autofluorescence.

• Super-resolution microscopy techniques (STED, STORM, SIM) can provide nanoscale localization of SAMM50 relative to other mitochondrial components.

Analysis Considerations:

• Quantitative image analysis should include colocalization measures (e.g., Pearson's correlation, Manders' overlap) between SAMM50 and other proteins of interest.

• When analyzing mitochondrial morphology in relation to SAMM50 distribution, appropriate segmentation algorithms should be employed to accurately identify mitochondrial networks.

What are the considerations for using SAMM50 antibodies in studies of mitochondrial dynamics and quality control?

Mitochondrial dynamics (fusion, fission) and quality control mechanisms are closely linked to SAMM50 function:

Experimental Design for Dynamics Studies:

• SAMM50 depletion affects protein content but preserves mitochondrial DNA nucleoids , suggesting a role in protein quality control rather than mitochondrial DNA maintenance.

• When studying mitochondrial dynamics, researchers should combine SAMM50 antibodies with markers of fusion (MFN1/2, OPA1) and fission (DRP1, FIS1) to determine whether SAMM50 alterations affect these processes.

Stress Response Analysis:

• SAMM50 and p62 cooperate to mediate efficient piecemeal mitophagy upon metabolic switch to OXPHOS .

• Researchers can design experiments involving metabolic stress (e.g., glucose deprivation, hypoxia) and monitor changes in SAMM50 expression, localization, and interaction partners.

• Time-course experiments following stress induction can reveal the dynamics of SAMM50's role in quality control responses.

Integration with Other Quality Control Pathways:

• SAMM50 depletion stabilizes PINK1 and increases processing of LC3B-I to LC3B-II , indicating cross-talk with canonical PINK1/Parkin-mediated mitophagy.

• Experiments should be designed to determine whether SAMM50-mediated and PINK1/Parkin-mediated pathways operate in parallel or have hierarchical relationships.

• The relationship between SAMM50-mediated processes and other mitochondrial quality control mechanisms (e.g., proteases, mitochondrial-derived vesicles) remains to be fully elucidated and represents an important research direction.